Morgan Stanley & Co. Int'l plc Stabilisation Notice

RNS Number : 2974X

Morgan Stanley & Co. Int'l plc

22 July 2024

 

22 July 2024

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Sani/Ikos Financial Holdings 1 S.A.R.L.

Post-stabilisation Period Announcement

Further to the pre-stabilisation period announcement dated 16 July 2024, MORGAN STANLEY & CO. INTERNATIONAL PLC (contact: Joseph Bishay; telephone: [phone]) hereby gives notice, that no stabilisation (within the meaning of Article 3.2(d) of the EU Market Abuse Regulation (596/2014), including as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018) was undertaken by the Stabilisation Manager(s) named below in relation to the offer of the following securities.

Securities

Issuer:	Sani/Ikos Financial Holdings 1 S.A.R.L.
Guarantor(s) (if any):	Sani/Ikos Group NewCo S.C.A. and Sani/Ikos Financial Holdings 2 S.A.R.L.
Aggregate nominal amount:	€350,000,000
Description:	€350,000,000 Senior Notes due 2030
ISIN:	Reg S: XS2864440321 144A: XS2864440594
Offer price:	Par

 

Stabilisation

Stabilisation Manager:

MORGAN STANLEY & CO. INTERNATIONAL PLC

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement is not an offer of securities for sale into the United States. The securities referred to above have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

END.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

STARTMMTMTTTBRI